STOCK TITAN

Cullinan Oncology to Present at Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Cullinan Oncology (Nasdaq: CGEM) will present at two virtual healthcare conferences in January 2022. The 40th Annual J.P. Morgan Healthcare Conference is scheduled for January 13 at 7:30 a.m. ET. A live webcast will be available on the company’s investor relations website. Additionally, the HC Wainwright BioConnect Conference will provide on-demand presentations starting January 10 at 7:00 a.m. ET. Details for registration and access can be found on their respective websites.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that it will present at the following virtual healthcare conferences in January:

40th Annual J.P. Morgan Healthcare Conference

  • Thursday, January 13 at 7:30 a.m. ET

HC Wainwright BioConnect Conference

  • Presentation available on-demand for registered conference attendees beginning Monday, January 10 at 7:00 a.m. ET

A live webcast of the J.P. Morgan presentation will be available via the Events section of the Company’s investor relations website at https://investors.cullinanoncology.com/news-events/events. Registration and other information about the HC Wainwright Conference can be found at https://hcwevents.com/bioconnect.

About Cullinan Oncology

Cullinan Oncology is a biopharmaceutical company that is developing a diversified pipeline of targeted therapeutic candidates across multiple modalities in order to bring important medicines to cancer patients. The Company’s strategy is to source innovation through both internal discovery efforts and external collaborations, focusing on advanced stage assets with novel technology platforms and differentiated mechanisms. Learn more about Cullinan at www.cullinanoncology.com.

Contacts:

Investor Relations
Lee Roth / Dr. Grace Kim
+1 212.213.0006
Lroth@burnsmc.com / gkim@burnsmc.com

Jeffrey Trigilio
+1 617.410.4650
jtrigilio@cullinanoncology.com

Media
Ariane Lovell
+1 917.565.2204
ariane.lovell@finnpartners.com


FAQ

When will Cullinan Oncology present at the J.P. Morgan Healthcare Conference?

Cullinan Oncology will present at the J.P. Morgan Healthcare Conference on January 13, 2022, at 7:30 a.m. ET.

How can I watch the Cullinan Oncology presentation at the J.P. Morgan Conference?

You can watch the Cullinan Oncology presentation live via the Events section on their investor relations website.

What is the schedule for the HC Wainwright BioConnect Conference presentation by Cullinan Oncology?

Cullinan Oncology's presentation at the HC Wainwright BioConnect Conference will be available on-demand starting January 10, 2022, at 7:00 a.m. ET.

Where can I find registration information for the HC Wainwright BioConnect Conference?

Registration information for the HC Wainwright BioConnect Conference can be found at hcwevents.com/bioconnect.

What is the stock symbol for Cullinan Oncology?

The stock symbol for Cullinan Oncology is CGEM.

Cullinan Therapeutics, Inc.

NASDAQ:CGEM

CGEM Rankings

CGEM Latest News

CGEM Stock Data

684.17M
52.75M
4.5%
118.78%
14.96%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE